tirzepatide for cardiovascular disease Outcomes with versus Dulaglutide in Type 2 Diabetes Tirzepatide Linked to Better CV

doi: 10.1016/j.micres.2018.09.011 36 SouliotisVLVlachogiannisNIPappaMArgyriouANtourosPASfikakisPP

Our peptides are research-grade only , distinct from clinical-grade USP/EP and not for human or veterinary administration

21 22 23 Fibre works in tandem with GLP-1 therapy to promote satiety, stabilise blood sugar, and support gut health, providing a dual-action mechanism for weight health

Studies have shown a reduction in major cardiovascular events among patients with type 2 diabetes, positioning semaglutide as a medication that transcends glucose control, offering a multifaceted approach to improving patient outcomes

It is also prescribed for adults with moderate to severe obstructive sleep apnea (OSA) linked to obesity

Suzuki Y, Suda T, Furuhashi K, et al